Edwards Lifesciences (EW) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free EW Stock Alerts $87.96 +0.93 (+1.07%) (As of 10:04 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Edwards Lifesciences Short Interest DataCurrent Short Interest8,000,000 sharesPrevious Short Interest9,630,000 sharesChange Vs. Previous Month-16.93%Dollar Volume Sold Short$721.28 millionShort Interest Ratio2.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares602,600,000 sharesFloat Size592,930,000 sharesShort Percent of Float1.35%Today's Trading Volume181,873 sharesAverage Trading Volume3,494,240 sharesToday's Volume Vs. Average5% Short Selling Edwards Lifesciences ? Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEW Short Interest Over TimeEW Days to Cover Over TimeEW Percentage of Float Shorted Over Time Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Edwards Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20248,000,000 shares $721.28 million -16.9%1.4%2.5 $90.16 4/30/20249,630,000 shares $815.47 million +30.5%1.6%2.7 $84.68 4/15/20247,380,000 shares $658.30 million -28.9%1.3%1.9 $89.20 3/31/202410,380,000 shares $991.91 million -0.7%1.8%2.6 $95.56 3/15/202410,450,000 shares $964.64 million +23.8%1.8%2.7 $92.31 2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87 Get the Latest News and Ratings for EW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06 1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47 1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03 12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25 12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90 11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71 11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01 10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72 10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78 9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28 9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20 8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47 8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86 7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07 7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38 6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33 6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29 5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24 5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92 4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98 4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36 3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73 3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48 2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44 2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92 1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70 1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31 12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61 12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55 11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25 11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96 10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43 10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42 9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88 8/31/20223,680,000 shares $331.57 million -27.0%0.6%1.4 $90.10 8/15/20225,040,000 shares $527.89 million -9.0%0.8%2 $104.74 7/31/20225,540,000 shares $556.99 million -16.8%0.9%2.1 $100.54 7/15/20226,660,000 shares $662.20 million +7.3%1.1%2.4 $99.43 6/30/20226,210,000 shares $590.51 million +5.8%1.0%2.2 $95.09 6/15/20225,870,000 shares $521.14 million -10.5%2.9%2 $88.78 5/31/20226,560,000 shares $661.58 million +27.4%1.1%2.3 $100.85 5/15/20225,150,000 shares $502.38 million +6.0%0.8%1.9 $97.55 4/30/20224,860,000 shares $514.09 million -15.2%0.8%1.8 $105.78 4/15/20225,730,000 shares $687.71 million +28.5%0.9%2.1 $120.02 3/31/20224,460,000 shares $525.03 million No Change0.7%1.7 $117.72 3/15/20224,460,000 shares $473.43 million -20.6%0.7%1.7 $106.15 2/28/20225,620,000 shares $631.52 million -11.1%0.9%2.1 $112.37 2/15/20226,320,000 shares $701.08 million +9.5%1.0%2.3 $110.93 1/31/20225,770,000 shares $630.08 million +6.5%0.9%2.2 $109.20 1/15/20225,420,000 shares $640.97 million -10.9%0.9%2.2 $118.26 12/31/20216,080,000 shares $787.66 million +10.0%1.0%2.6 $129.55 12/15/20215,530,000 shares $663.10 million -3.8%0.9%2.2 $119.91 11/30/20215,750,000 shares $617.03 million +4.0%0.9%2.5 $107.31 11/15/20215,530,000 shares $645.30 million -20.2%0.9%2.6 $116.69 10/29/20216,930,000 shares $830.35 million +6.0%1.1%3.3 $119.82 10/15/20216,540,000 shares $733.53 million +7.6%1.1%3.2 $112.16 9/30/20216,080,000 shares $688.32 million +2.7%1.0%2.8 $113.21 9/15/20215,920,000 shares $716.44 million -2.0%1.0%2.8 $121.02 8/31/20216,040,000 shares $707.77 million +0.8%1.0%2.8 $117.18 8/13/20215,990,000 shares $677.77 million -1.3%1.0%2.6 $113.15 7/30/20216,070,000 shares $681.48 million -8.9%1.0%2.6 $112.27 7/15/20216,660,000 shares $708.22 million +20.4%1.1%2.8 $106.34 6/30/20215,530,000 shares $572.74 million -9.1%0.9%2.2 $103.57 6/15/20216,080,000 shares $609.70 million +4.5%1.0%2.4 $100.28 5/28/20215,820,000 shares $558.14 million -2.8%0.9%2.3 $95.90 5/14/20215,990,000 shares $526.76 million -13.4%N/A2.2 $87.94 4/30/20216,920,000 shares $666.12 million +5.2%N/A2.5 $96.26 4/15/20216,580,000 shares $567.53 million +24.6%N/A2.3 $86.25 3/31/20215,280,000 shares $437.45 million -2.6%N/A2 $82.85 3/15/20215,420,000 shares $444.82 million -3.0%N/A2.1 $82.07 2/26/20215,590,000 shares $469.39 million -17.1%N/A2.2 $83.97 2/12/20216,740,000 shares $593.59 million +50.8%N/A2.8 $88.07 1/29/20214,470,000 shares $372.71 million +3.5%N/A1.8 $83.38 1/15/20214,320,000 shares $377.96 million -6.9%N/A1.7 $87.49 12/31/20204,640,000 shares $415.93 million -5.7%N/A1.9 $89.64 12/15/20204,920,000 shares $411.16 million -7.5%N/A2 $83.57 11/30/20205,320,000 shares $453.58 million +6.0%N/A2.1 $85.26 11/15/20205,020,000 shares $410.54 million +0.8%N/A1.9 $81.78 10/30/20204,980,000 shares $363.09 million -29.7%N/A2 $72.91 10/15/20207,080,000 shares $603.00 million +5.8%N/A3 $85.17 9/30/20206,690,000 shares $534.00 million -2.8%N/A2.6 $79.82 9/15/20206,880,000 shares $573.10 million -5.0%N/A2.6 $83.30 8/31/20207,240,000 shares $621.48 million +15.7%N/A2.7 $85.84Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 8/14/20206,260,000 shares $488.72 million -3.4%N/A2.2 $78.07 7/31/20206,480,000 shares $508.10 million -12.0%N/A2.2 $78.41 7/15/20207,360,000 shares $524.18 million -7.1%N/A2.3 $71.22 6/30/20207,920,000 shares $537.69 million +8.9%N/A2.4 $67.89 6/15/20207,270,000 shares $501.34 million +206.8%N/A1.9 $68.96 5/29/20202,370,000 shares $532.59 million -4.1%N/A0.5 $224.72 5/15/20202,470,000 shares $175.34 million +3.8%1.2%1.5 $70.99 4/30/20202,380,000 shares $172.55 million -4.0%1.2%1.4 $72.50 4/15/20202,480,000 shares $177.44 million -18.7%1.2%1.4 $71.55 3/31/20203,050,000 shares $681.61 million +31.3%1.5%1.7 $223.48 3/13/20202,322,900 shares $500.45 million +7.5%1.1%1.6 $215.44 2/28/20202,160,000 shares $339.62 million +4.4%1.0%1.4 $157.23 2/14/20202,070,000 shares $419.94 million +1.5%1.0%1.6 $202.87 1/31/20202,040,000 shares $452.02 million -14.3%1.0%1.6 $221.58 1/15/20202,380,000 shares $550.14 million +1.3%1.2%1.9 $231.15 12/31/20192,350,000 shares $541.56 million +18.7%1.1%2 $230.45 8/15/20192,255,600 shares $486.44 million -4.0%1.1%1.8 $215.66 EW Short Interest - Frequently Asked Questions What is Edwards Lifesciences' current short interest? Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 8,000,000 shares of EW short. 1.35% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest. What is a good short interest ratio for Edwards Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 2.0. Learn More on Edwards Lifesciences's short interest ratio. Which institutional investors are shorting Edwards Lifesciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: Walleye Trading LLC, Jane Street Group LLC, Paloma Partners Management Co, PEAK6 Investments LLC, Twin Tree Management LP, BNP Paribas Financial Markets, SpiderRock Advisors LLC, Caas Capital Management LP, Wealth Enhancement Advisory Services LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Edwards Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.35% of Edwards Lifesciences' floating shares are currently sold short. Is Edwards Lifesciences' short interest increasing or decreasing? Edwards Lifesciences saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 8,000,000 shares, a decline of 16.9% from the previous total of 9,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edwards Lifesciences' float size? Edwards Lifesciences currently has issued a total of 602,600,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 592,930,000 shares. How does Edwards Lifesciences' short interest compare to its competitors? 1.35% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies compare to Edwards Lifesciences: Abbott Laboratories (0.85%), Intuitive Surgical, Inc. (1.03%), Stryker Co. (1.15%), Boston Scientific Co. (0.84%), Medtronic plc (1.15%), Becton, Dickinson and Company (0.68%), DexCom, Inc. (1.96%), IDEXX Laboratories, Inc. (2.07%), ResMed Inc. (6.95%), STERIS plc (2.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Edwards Lifesciences stock? Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edwards Lifesciences? A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further. How often is Edwards Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ABT Short Squeeze ISRG Short Squeeze SYK Short Squeeze BSX Short Squeeze MDT Short Squeeze BDX Short Squeeze DXCM Short Squeeze IDXX Short Squeeze RMD Short Squeeze STE Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EW) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.